Suppr超能文献

具有高稳定性用于长期超声成像的全氟戊烷填充壳聚糖聚丙烯酸纳米气泡

Perfluoropentane-filled chitosan poly-acrylic acid nanobubbles with high stability for long-term ultrasound imaging .

作者信息

Gao Xuemei, Guo Dajing, Mao Xiang, Shan Xuefeng, He Xuemei, Yu Chaoqun

机构信息

Department of Radiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.

State Key Laboratory of Ultrasound in Medicine and Engineering & Chongqing Key Laboratory of Biomedical Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, P. R. China.

出版信息

Nanoscale. 2021 Mar 18;13(10):5333-5343. doi: 10.1039/d0nr06878k.

Abstract

Reducing the size of ultrasound contrast agents (UCAs) will decrease the intensity of the ultrasound echogenic signals and reduce the stability of the bubbles. Therefore, it is a challenge to design nanobubbles that are less than 200 nm in size and that have both good imaging abilities and high stability for long-term imaging in vivo. In this work, we successfully prepared perfluoropentane-filled chitosan poly-acrylic acid (PFP-CS-PAA) nanobubbles with a size of about 100 nm via a direct simple core-template-free strategy. In vitro tests demonstrated that the nanobubbles showed satisfactory imaging capabilities in non-linear harmonic imaging mode and had significantly better stability than commercial Sonovue® lipid microbubbles. It was valuable to discover that the prepared PFP-CS-PAA nanobubbles could exhibit good imaging quality in rat livers for 10 min after intravenous injection. Also, the PFP-CS-PAA nanobubbles could maintain imaging capabilities in nude mouse tumors for 7 days after intratumoral injection, which indicated that these nanobubbles could keep their stability for a long time in vivo. To the best of our knowledge, the ultrasound imaging persistence time in vivo was the longest of currently reported polymer nanobubbles that are smaller than 200 nm. This new nanosized UCA with high stability has great potential for long-term ultrasound imaging in vivo. Tumor cellular uptake and histological analysis revealed that PFP-CS-PAA nanobubbles could be taken up into tumor cells, but no intracellular uptake was observed in the case of Sonovue®. Animal fluorescence imaging in vivo demonstrated that PFP-CS-PAA nanobubbles could be effectively cleared after intravenous injection within 168 h. MTT assays indicated that PFP-CS-PAA nanobubbles had appropriate biocompatibility. Abnormal levels of blood urea nitrogen were detected after the intravenous administration of PFP-CS-PAA nanobubbles to rats, and body-weight gain was inhibited for up to 6 d, but, after that, body weights recovered their tendency to increase.

摘要

减小超声造影剂(UCAs)的尺寸会降低超声回声信号的强度,并降低气泡的稳定性。因此,设计尺寸小于200 nm且具有良好成像能力和高稳定性以用于体内长期成像的纳米气泡是一项挑战。在本工作中,我们通过一种直接的、简单的无核心模板策略成功制备了尺寸约为100 nm的全氟戊烷填充的壳聚糖聚丙烯酸(PFP-CS-PAA)纳米气泡。体外测试表明,这些纳米气泡在非线性谐波成像模式下显示出令人满意的成像能力,并且稳定性明显优于市售的声诺维®脂质微泡。值得注意的是,静脉注射后,所制备的PFP-CS-PAA纳米气泡在大鼠肝脏中可在10分钟内呈现良好的成像质量。此外,PFP-CS-PAA纳米气泡在瘤内注射后可在裸鼠肿瘤中保持成像能力7天,这表明这些纳米气泡在体内可长时间保持其稳定性。据我们所知,这种体内超声成像持续时间是目前报道的尺寸小于200 nm的聚合物纳米气泡中最长的。这种具有高稳定性的新型纳米级超声造影剂在体内长期超声成像方面具有巨大潜力。肿瘤细胞摄取和组织学分析表明,PFP-CS-PAA纳米气泡可被肿瘤细胞摄取,但声诺维®则未观察到细胞内摄取。体内动物荧光成像表明,静脉注射后,PFP-CS-PAA纳米气泡可在168小时内有效清除。MTT分析表明,PFP-CS-PAA纳米气泡具有适当的生物相容性。给大鼠静脉注射PFP-CS-PAA纳米气泡后,检测到血尿素氮水平异常,体重增加受到抑制长达6天,但之后体重恢复了增加的趋势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验